Post by MediPocket

I want to start this issue with a number. 158,850. That is the number of new colorectal cancer cases estimated in the United States alone in 2026, according to the American Cancer Society's most recent report published this March. 55,230 people will die from the disease this year. These are significant numbers. But they are not the number I want you to remember. The number I want you to remember is this: 1 in 5. One in five colorectal cancer diagnoses now occurs in someone under the age of 55. Let that settle for a moment. This is not a disease that arrives in the final chapters. It is arriving in the middle of a career. In the decade before retirement. In the years when most people in this professional community are at their most productive, their most influential, their most indispensable. And according to the 2026 Colorectal Cancer Statistics report from the American Cancer Society, colorectal cancer is now the leading cause of cancer-related deaths among adults under 50. Not the second. The first. Overtaking breast cancer and prostate cancer in that age group. Surpassing them entirely. Rectal cancer incidence, specifically, reversed decades of decline — rising 1% per year from 2018 to 2022- and rectal cancer now accounts for about one-third of all colorectal cancer diagnoses, up from one-fourth in prior years. American Cancer Society Among adults aged 15 to 39, the incidence rate rose 47.5% over the past few decades, with an annual percent change of 2% per year. PubMed Central This is not a slow trend. It is an acceleration. Read the full newsletter to know more!! . . . . #newsletter #newsletters #colorectalcancer #cancer #oncology #oncologist #specialist #USA #India #Clinicaltrial #trials #Internationalpatients #patients #doctors